Posterity Health, the “center of excellence for male reproductive health”, announced the closing of a $6M round of financing led by FCA Venture Partners and supported by Distributed Ventures and WVV. The incremental funding will be used to accelerate the development of the Posterity Health Male Management Platform (MMP), launch new services, and expand the executive team. Posterity Health’s goal is to empower males to take control of their reproductive health.
The Posterity Health Male Management Platform (MMP) combines technology, expert care teams, and AI-driven clinical protocols to drive personalized end-to-end male care. The MMP is designed to facilitate efficient access, enabling the company to scale rapidly and provide access to more males. It enables Posterity Health to contact 99% of patients on the same day they receive their referral and see 75% of patients within two weeks. Trained reproductive urologists and their specialized care teams drive a hybrid care delivery model, allowing for telehealth appointments and in-person care. This model ensures continuity of care and includes MMP data analytics and AI modules, allowing the company to unlock the power of the clinical data collected. The platform will enable real-time research, providing new insights into male fertility care and treatment.
Hormone Management is a $3.2 billion market in the United States. The fresh funds enable Posterity Health to expand beyond fertility to provide a full suite of reproductive services, including Low-T services.
To facilitate its growth the company also welcomes new members to the leadership team. Matt Alley joins as Chief Operating Officer and most recently served as Sr. Director of Fulfillment Strategy at Hello Fresh. He comments: “I’m excited to contribute to Posterity Health’s vision of making significant advancements in male reproductive health. We are committed to innovation and excellence in every aspect of our patient care.”
Matt Lenz was promoted to Chief Growth Officer. Prior to joining Posterity Health, Lenz served as Vice President of Sales at Teladoc. He also led teams at Livongo (acquired by Teladoc), Netsmart Technologies, and HealthMEDX. Matt and his team support obgyn and fertility center partners and manage strategic relationships with the leading fertility benefit managers. “Developing and leading the team at Posterity Health has been a career highlight”, he says. “The growth we’ve seen over the past couple of years demonstrates the need for quality, easy-to-access male care.”
“These executive leaders share a common vision to provide every male with the knowledge, resources, and support to optimize their reproductive health,” says Pam Pure, Co-founder and CEO. “We are excited about this important next chapter of growth and innovation.”
